Life sciences and biotechnology have traditionally been the domain of big corporations and universities with vast resources. But with greater computing power and new gene-editing technologies, the field is becoming more accessible to startups.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3